Lava Therapeutics
LVTX
$2.26
Share price
-5.83%
Change (1 day)
18.95%
Change (1 year)
Categories
Lava Therapeutics (LVTX) - Cash on Hand
Cash on Hand as of March 2024 : $94.57 M
According to Lava Therapeutics's latest financial reports the company has $94.57 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Lava Therapeutics - Cash on Hand chart (from 2022 to 2021)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.13 B | -11.92% |
| 2021-12-31 | $0.15 B | 675.35% |
| 2020-12-31 | $19.45 M | 136.68% |
| 2019-12-31 | $8.22 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.31 B | 234.96% | 🇺🇸 USA |